Verici Dx plc announced that it has appointed Angela Rose as Senior Director, Clinical Trial Operations with immediate effect. Angela, a senior clinical trial project management professional with over 15 years of experience in managing medical device, diagnostics, biologic and drug global clinical trial operations for regulatory approval, will be responsible for overseeing Verici Dx's planned multi-centre observational clinical validation studies for its two in vitro diagnostic assays, Clarava and Tuteva. Angela joins Verici Dx from Humacyte Inc. Angela's extensive experience in clinical project management includes prior roles at BioCryst Pharmaceuticals Inc., Quintiles, Gilead Sciences Inc., and bioMérieux Inc.